News from NORD

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone

Publish date: April 14, 2017

 

The Foundation for Prader-Willi Research has published a blog and brochure regarding recent findings related to use of growth hormone for those affected by Prader-Willi syndrome.

Recommended Reading

NORD Submits Letter to Congress on Pre-Existing Conditions
Clinician Reviews
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
Clinician Reviews
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
Clinician Reviews
NORD Announces Recipients of 2017 Rare Impact Awards
Clinician Reviews
NORD and Neurology Reviews Publish Special Report
Clinician Reviews
Save the Date for the 2017 NORD Summit
Clinician Reviews
Film Festival Devoted to Rare Diseases Scheduled for October
Clinician Reviews
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
Clinician Reviews
Largest-Ever Study of Pemphigus and Pemphigoid Launched
Clinician Reviews
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
Clinician Reviews